MICROVISION, INC. (MVIS) Form 424B5 — Aug 13, 2026
MicroVision filed a preliminary prospectus supplement for a best-efforts public offering of common stock (or pre-funded warrants in lieu) paired with common warrants, with WestPark Capital as placement agent earning a 6.5% cash fee plus up to $90,000 in expenses. There is no minimum offering amount, and share count, price, and proceeds are blank pending pricing; the stock last closed at $3.39 on August 11, 2026. Each unit includes one Common Warrant exercisable into one share with a five-year term, while pre-funded warrants carry a $0.001 exercise price for buyers who would otherwise breach 4.99% or 9.99% ownership limits.
Key figures
- Shares Outstanding
- 23788853
- Shelf capacity
- $50,000,000 (Registration No. 333-297430)
- Equity plan reserve
- 1,226,804 shares
- Options outstanding
- 36,818 shares at weighted average exercise price of $20.26
- Placement agent fee
- 6.5% of aggregate gross proceeds
- Reverse split ratio
- 1-for-15 (effective August 1, 2026)
- Q2 2026 loss per share
- $1.66
- Net tangible book value
- $3.3 million ($0.14 per share) as of June 30, 2026
- Unvested deferred awards
- 263,915 shares
- Closing price aug 11 2026
- $3.39
- Authorized shares post split
- 150,000,000 common; 25,000,000 preferred
- Shares outstanding june 30 2026
- 23350027
- Pre funded warrant exercise price
- $0.001
- Closing price jul 10 2026 pre split
- $0.38
- Placement agent expense reimbursement
- up to $90,000
- Twelve month trading range post split
- $3.11 - $23.10
Price after filing
Close on the filing date to close N calendar days later (from $3.64). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.